FDA
approval
· 2021-11-04
FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (ANI Pharmaceuticals, Inc.)
Summary
FDA approved ANI Pharmaceuticals' generic fixed-dose combination tablet of bisoprolol fumarate and hydrochlorothiazide for hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE)